We’re excited to announce that HitChem will be attending the 23rd Nexus Meeting, taking place on May 7^th and 8^th in Embassy Suites by Hilton, San Francisco! As a leading event in early drug discovery, Nexus brings together R&D leaders from biotech and pharma to share knowledge and present transformative technologies.

At HitChem, we’re advancing early-stage drug discovery through AI-driven molecular design and next-generation screening libraries. Don’t miss the talk by our VP of Drug Discovery, Dr. Zhang, titled “Leveraging Generative AI to Develop CRBN Molecular Glue Libraries for Efficient HTS and Rational Design.”

Come meet our team at our booth and learn how we’re redefining hit discovery — we look forward to connecting with you at Nexus!